findmyKOL
Clinical trialNCT00074906CompletedPhase 3Interventional

Venticute in Patients With Pneumonia or Aspiration of Gastric Contents and Intubation/Ventilation/Oxygenation Impairment (BY2001/M1-007)

SponsorTakedaEnrollment1,200Pneumonia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Study to demonstrate that administration of Venticute increases survival of patients with pneumonia or aspiration of gastric contents leading to intubation, mechanical ventilation, and severe oxygenation impairment.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Andreas Günther, MD

    University of Giessen

    Principal Investigator
    clinicaltrials.gov ↗
  • Roger G. Spragg, MD

    University of California and La Jolla Veterans Affairs Medical Center, San Diego, CA, USA

    Principal Investigator
    clinicaltrials.gov ↗
  • Werner Seeger, MD

    Justus-Liebig-Universität, Gießen, Germany

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

92 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Altana Pharma/nycomed

    Adelaide SA, Australia

  • Altana Pharma/nycomed

    Bedford Park, Adelaide S, Australia

  • Altana Pharma/nycomed

    Clayton, VIC, Australia

  • Altana Pharma/nycomed

    Fremantle, WA, Australia

  • Altana Pharma/nycomed

    Heidelberg, Victoria, Australia

  • Altana Pharma/nycomed

    Kingswood, Sydney, NS, Australia

  • Altana Pharma/nycomed

    Melbourne VIC, Australia

  • Altana Pharma/nycomed

    Perth, Western Australi, Australia

  • Altana Pharma/nycomed

    Southport Gold Coast QL, Australia

  • Altana Pharma/nycomed

    Victoria, Australia

  • Altana Pharma/nycomed

    Victoria, Australia

  • Altana Pharma/nycomed

    Woolloongabba, Queens, Australia

Austria
  • Altana Pharma/nycomed

    Linz, Austria

  • Altana Pharma/nycomed

    Vienna, Austria

Belgium
  • Altana Pharma/nycomed

    Brussels, Belgium

  • Altana Pharma/nycomed

    Brussels, Belgium

  • Altana Pharma/nycomed

    Edegern, Belgium

  • Altana Pharma/nycomed

    Ghent, Belgium

Denmark
  • Altana Pharma/nycomed

    Copenhagen NV, Denmark

  • Altana Pharma/nycomed

    Hvidovre, Denmark

  • Altana Pharma/nycomed

    Kolding, Denmark

Estonia
  • Altana Pharma/nycomed

    Tallinn, Estonia

  • Altana Pharma/nycomed

    Tartu, Estonia

Finland
  • Altana Pharma/nycomed

    Jyväskylä, Finland

  • Altana Pharma/nycomed

    Kuopio, Finland

  • Altana Pharma/nycomed

    Lappeenranta, Finland

  • Altana Pharma/nycomed

    Oulu, Finland

  • Altana Pharma/nycomed

    Tampere, Finland

  • Altana Pharma/nycomed

    Turku, Finland

Germany
  • Altana Pharma/nycomed

    Berlin, Germany

  • Altana Pharma/nycomed

    Bonn, Germany

  • Altana Pharma/nycomed

    Dresden, Germany

  • Altana Pharma/nycomed

    Giessen, Germany

  • Altana Pharma/nycomed

    Greifswald, Germany

  • Altana Pharma/nycomed

    Hanover, Germany

  • Altana Pharma/nycomed

    Hofheim, Germany

  • Altana Pharma/nycomed

    Konstanz, Germany

  • Altana Pharma/nycomed

    Lübeck, Germany

  • Altana Pharma/nycomed

    München, Germany

  • Altana Pharma/nycomed

    Regensburg, Germany

52 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Venticute
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2003
Primary completion
31 Mar 2008
Completion
30 Jun 2008
Last update posted
7 May 2012
Registered enrollment
1,200
Registry id
NCT00074906
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.